- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Paul Stanger, MD, MS
Pediatric Cardiology- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Paul Stanger, MD, MS
Pediatric Cardiology- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
About me
Education & training
Board certification
- Pediatric Cardiology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Cardiology, UCSF Medical Center - OMAG
- Cardiac Pathology, United Hospital
Residency
- Pediatrics, Fairview University of MN Hospital and Clinic
Internship
- Pediatrics, Fairview University of MN Hospital and Clinic
Degree
- MD, State University of New York (SUNY) at Buffalo
My expertise
Specialties
- Pediatric Cardiology
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%22332%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22332%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.